DIN 02230394 — TEVA-OXYBUTYNIN 5 MG
TEVA-OXYBUTYNIN is a tablet of Oxybutynin marketed by TEVA CANADA LIMITED. The full Oxybutynin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02230394
- Brand name
- TEVA-OXYBUTYNIN
- Active ingredient
- Oxybutynin
- Strength
- 5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Anticholinergic / antispasmodic agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Oxybutynin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02231089 | APO-OXYBUTYNIN | 1 MG | SYRUP | APOTEX INC | DORMANT |
| 02163543 | APO-OXYBUTYNIN | 5 MG | TABLET | APOTEX INC | MARKETED |
| 02240549 | PMS-OXYBUTYNIN | 2.5 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02223376 | PMS-OXYBUTYNIN | 5 MG | SYRUP | PHARMASCIENCE INC | MARKETED |
| 02240550 | PMS-OXYBUTYNIN | 5 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02299364 | RIVA-OXYBUTYNIN | 5 MG | TABLET | LABORATOIRE RIVA INC. | DORMANT |